Webinars

During this webinar, we will evaluate stability data of several small molecule drugs for cancer belonging to the microtubule inhibitor drug class (docetaxel, paclitaxel), topoisomerase inhibitors (etoposide), as well as hormone-based oncology drugs (fulvestrant). We will show you how we can optimise oncological drug delivery resulting in long-term formulation stability, extended drug shelf life, and ultimately improved drug performance and efficacy.